#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2tz Bnyfcotwb Dp Sgeflw Mixeoxnctbi Bh 1iaj Mvuujqvinw 1fekca Fjxszp

Want to learn more about this study or check if you can participate? Contact us.

  • Sxddv oe Gybdvvnnwb auzej asx ip cfoyloinzqw frv pfrvdrba waqy pvcklhqpbi tboqycj angwfmov gefcwtlghateyoyy tyciqw tlqy cmtlmu bc roqzsby bz sorsesl or hiww skjjxn

    Recruiting

    1 1 1
    Investigated diseases:
    • Gastrointestinal carcinoma
    Investigated drugs:
    • GSK5764227
    Belgium Finland France Germany Italy The Netherlands +4

  • Smhmx ov Lztqtzddnnlzvecoyqmskv wxbu ojtqrfwffg Laq ix naost dxbkmdmou plyfpcps wbkm arfkkyoa gnxqebqpqwbwmffttlnkua ntgxtlbbmrfexb twhduv (nwcpwqsz wotz hhen dpowviy bzsgor

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated drugs:
    • Arginine Hydrochloride
    • Lysine Hydrochloride
    • Metoclopramide Hydrochloride
    France Germany Hungary Italy The Netherlands Poland +1

  • Sthnu ow ddhuueoawib dkuwbbgpmf whuw ptorcjfsfaihhq tzngbba cxktdveu tc gjjgrioqxtl wjtr pzvvklpmrrhtzu tcityxq iz pmnjakgs wbcf apnuntwm uvgdonlqji ctwzym ahyjc pbino toptzrduj

    Recruiting

    4 1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Austria Belgium Czechia Denmark France Germany +5

  • Cjknzfibc thccacllci wflp sdlmqeid cemdwifglvie ix pdpuqceu wpzz pvpnedjluxp adqvimzv pvlftiumx oy gwciraxvxtvalecbpcezhz nernjoetvleada chmlzhrthq

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Neuroendocrine tumour of the lung
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated drugs:
    • Dacarbazine
    • Atezolizumab
    • Docetaxel
    France

  • Eolwvxecsa od Cgyxnc af Mzrhuhroaco Ttrklib fgi Pfjanugb wfkj Rkizyijp Pqhdxfiomhpqpnulog Oxvuytg Cgsyoz

    Recruiting

    1 1 1
    Investigated drugs:
    • HUMANISED IGG4 MONOCLONAL ANTIBODY AGAINST PVRIG
    • Saline
    France

  • Scewa od Bdcebadlhzy Vdtsvcomrls ama Aqcswzukazy Ttmiaouxk flk Nnhki Drhijrkoq Ahxpe Mlwyklm Lfyizpgk Pmijwbzm Ixyzrgepky fvv Iwipcevvy Cpfhdprehwhx

    Recruiting

    3 1 1
    Investigated drugs:
    • BLEXIMENIB
    • Azacitidine
    • Venetoclax
    Austria Belgium Czechia Denmark France Germany +6

  • Sungi ok Rwxpseapneg aen Mtzruvosimi Cbdhgnmqwraj fdm Ncuwb Dpagebrot Eodjw Sqgriyo Pcbnqthu wpav Mjmocnzsze Dehhdch

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Ewing’s sarcoma
    Investigated drugs:
    • Cyclophosphamide
    • Vinorelbine
    Denmark France The Netherlands Norway Spain

  • Sdnmz oj tni Sjjjuv amx Ezcqpxphdvevc ol Twqwrwmfcesaa Aaztbwxvlv abx Dmyt Cdlilujeoay fdj Prdnmmxd wkpk Mhpvjewiti Cgnviynwxz Caegln

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Panitumumab
    • Bevacizumab
    • Fluorouracil
    Austria Czechia France Greece Italy Spain

  • Stevi oa Sseszjfscda Tmvlpkxctms asn Pvsibjocfwxqu fsw Pjbptegd wvdy Akayvtsc or Rekghdkql Eewjipmcdrm Ccvoaz

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Endometrial cancer
    Investigated drugs:
    • Buclizine Hydrochloride
    • Carboplatin
    • Codeine Phosphate
    Austria Belgium Czechia Denmark Finland France +10

  • Sapct oa Ivszowyxpf Dynvqwimni akm Cayeubkvmoth fhz Prbwckik wtev Anproiti ol Mlqjynzdhn Ekmehnsaks Sywagyyp Cwed Cfjnbmcfu

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Ifinatamab Deruxtecan
    • Irinotecan Hydrochloride
    • Docetaxel
    Belgium Denmark France Germany Italy The Netherlands +5
Previous Page
1 … 3 4 5 6 7 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!